AMERISAFE INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AMERISAFE INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $317.25M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $309.04M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $306.85M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $294.74M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $315.93M | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $88.22M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $83.01M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $89.08M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $79.17M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $91.94M | Feb 26, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $47.15M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $55.44M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $62.11M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $55.60M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $65.76M | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $28.50M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $23.35M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $23.95M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $10.80M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $34.01M | Feb 26, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.07M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $24.19M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $29.84M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $28.19M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $37.98M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $63.40M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $78.82M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $98.27M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $130.81M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $114.21M | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.15M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $840.0K | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $553.0K | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $2.09M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $1.30M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $921.0K | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $1.02M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.13M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $478.0K | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $1.64M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.13B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.16B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.23B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.27B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.40B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $1.47B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $1.49B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.52B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $1.52B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $1.52B | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $878.95M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $900.45M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $936.71M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $951.85M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.00B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $1.03B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $1.06B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.11B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $1.09B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $1.06B | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $251.60M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $257.34M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $292.45M | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $317.43M | Feb 27, 2026 |
| FY2024 | Dec 31, 2021 | $399.32M | Feb 28, 2025 |
| FY2023 | Dec 31, 2020 | $438.82M | Feb 23, 2024 |
| FY2022 | Dec 31, 2019 | $430.22M | Feb 21, 2023 |
| FY2021 | Dec 31, 2018 | $409.76M | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $425.42M | Feb 26, 2021 |
| FY2019 | Dec 31, 2016 | $456.15M | Feb 25, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $82.85M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $84.11M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $114.29M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $145.51M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $190.49M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $224.65M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $227.17M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $221.33M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $233.90M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $270.42M | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $61.93M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $44.05M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $38.68M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $61.47M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $70.72M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $61.76M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $43.81M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $40.34M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $55.56M | Feb 28, 2019 |
| FY2018 | Dec 31, 2016 | $58.94M | Feb 28, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 26, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 26, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18.79M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 19.05M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 19.14M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | 19.16M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | 19.36M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | 19.33M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 19.30M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | 19.27M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | 19.25M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | 19.23M | Feb 28, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $48.61M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $85.44M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $93.31M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $100.43M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $99.93M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $88.78M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $87.02M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $84.49M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $82.65M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $76.11M | Feb 28, 2019 |